Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03778099Phase 3Completed
Phase 3, randomised, double-blind trial (2 arms), sponsored by King Abdulaziz University. Primary endpoints: Ovulation Confirmation by Progesterone level at 3 months, Changes in insulin resistance at 3 months and 2 more. Started Sep 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03778099.